tiprankstipranks
Advertisement
Advertisement

XERS Stock Latest News

Xeris Biopharma announces notice of allowance from USPTO for Keveyis patent
The FlyXeris Biopharma announces notice of allowance from USPTO for Keveyis patent
16d ago
XERS
Xeris Biopharma Announces Debt Reduction via Note Exchanges
PremiumCompany Announcements
Xeris Biopharma Announces Debt Reduction via Note Exchanges
17d ago
8K
XERS
Xeris Biopharma announces private exchange of convertible notes
PremiumThe Fly
Xeris Biopharma announces private exchange of convertible notes
17d ago
XERS
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
PremiumCompany Announcements
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
22d ago
8K
XERS
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
PremiumCompany Announcements
Xeris Pharmaceuticals Signals Profitable Growth Acceleration
2M ago
XERS
Xeris Biopharma reports Q1 EPS 1c, consensus 0c
PremiumThe FlyXeris Biopharma reports Q1 EPS 1c, consensus 0c
2M ago
XERS
Xeris Biopharma Announces Board Transition as Director Retires
Premium
Company Announcements
Xeris Biopharma Announces Board Transition as Director Retires
2M ago
8K
XERS
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
Premium
Company Announcements
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
4M ago
XERS
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
PremiumTipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
4M ago
NSRX
XERS
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
PremiumThe Fly
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
4M ago
XERS
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
PremiumThe Fly
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
4M ago
XERS
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
4M ago
XERS
Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
PremiumThe FlyXeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
4M ago
XERS
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
Premium
Market News
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
4M ago
COF
VIR
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
Premium
Ratings
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
6M ago
XERS
Xeris Biopharma initiated with an Overweight at Barclays
PremiumThe Fly
Xeris Biopharma initiated with an Overweight at Barclays
7M ago
XERS
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
PremiumCompany Announcements
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
7M ago
8K
XERS
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
PremiumThe Fly
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
7M ago
XERS
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
PremiumThe Fly
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
8M ago
XERS
Xeris Pharmaceuticals: Strong Growth Potential and First Profitable Quarter Drive Buy Rating
PremiumRatingsXeris Pharmaceuticals: Strong Growth Potential and First Profitable Quarter Drive Buy Rating
8M ago
XERS
Xeris Biopharma Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Xeris Biopharma Reports Strong Q3 2025 Financial Results
8M ago
XERS
Xeris Biopharma Reports Record Revenue Growth in Earnings Call
Premium
Company Announcements
Xeris Biopharma Reports Record Revenue Growth in Earnings Call
8M ago
XERS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >